IGFBP-1 and fFN combined test
Date:
October 19, 2026
Category:
Combined test of iGFBP-1 and fFN
One sample detects IGFBP-1 and fetal fibronectin for the assessment of amniotic fluid leakage and the risk of preterm birth. For professional use (in vitro diagnostics).
Contact our sales team for availability and delivery time
What is this test?
The combined vaginal discharge test detects phosphorylated insulin-like growth factor-binding protein-1 (phIGFBP-1) and fetal fibronectin (fFN). It is used in obstetrics as an aid in assessing the risk of preterm labor in pregnant women with uterine contractions or other symptoms.
Technical information
- Method
- Lateral flow chromatographic immunoassay
- Result in
- 10 min
- Storage temperature
- 2–30 °C
- Equipment
- Not required – visual reading
- Compliance
- CE-marked in vitro diagnostic device
Variants and order codes
| Code | Specimen | Format | Pack size |
|---|---|---|---|
| AF-3QSHZF | Vaginal secretion | Cassette | 25 tests |